Investor RelationsLatest News InMed Announces Publication of Peer-Reviewed Study Showing the Anti-Inflammatory Potential of Rare Cannabinoids in Skin Conditions March 13, 2023 Read More » InMed to Participate in Upcoming Investor Events March 6, 2023 Read More » InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business Update February 17, 2023 Read More » InMed Submits Form 12b-25 February 9, 2023 Read More » Latest Events VirtualInvestorConferences.com – Life Sciences Investor Forum March 3, 2023 Read More » Emerging Growth Conference March 3, 2023 Read More » Tribe Public’s Webinar Event “Exploring the Neuroprotective Qualities of Rare Cannabinoids” November 10, 2022 Read More » Force For Knowledge Cannabis Symposium – Jump Starting Cannabis Valuations 101 June 27, 2022 Read More » Stock Information NASDAQ:INM stock price by TradingView See Stock Information Presentations Corporate Presentation – March 2023 View Presentation View All Presentations Latest Financial Reports2023Q1Quarterly Press Release 10-QQ2Quarterly Press ReleaseFinancial StatementsMD&A View All Financial Reports Latest SEC Filings Investor Alerts Sign up for investor alerts! Sign Up Information Request Send us a request for information Learn More
InMed Announces Publication of Peer-Reviewed Study Showing the Anti-Inflammatory Potential of Rare Cannabinoids in Skin Conditions March 13, 2023 Read More »
InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business Update February 17, 2023 Read More »
Tribe Public’s Webinar Event “Exploring the Neuroprotective Qualities of Rare Cannabinoids” November 10, 2022 Read More »
Force For Knowledge Cannabis Symposium – Jump Starting Cannabis Valuations 101 June 27, 2022 Read More »